ENTITY
Bayer

Bayer (BAYN GY)

27
Analysis
Health Care • Germany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullish•Macroeconomics
•09 Dec 2021 02:36

Germany: Scholz-Led Traffic-Light Coalition to Redefine Left-Wing Pragmatism

The new coalition will borrow in 2022, & invest in a green, digital transformation over the next 5 years. Germany's large current account surplus...

Logo
446 Views
Share
bullish•MSCI ACWI Index
•20 Feb 2020 07:53

Global Equity Strategy: Buy the Dips

Despite recent weakness across global markets, our weight of the evidence approach continues to lead us to the same conclusions as we posited in...

Logo
556 Views
Share
•29 Jan 2020 07:51

EM Pullback Opportunity

Supporting our global bull market thesis, uptrends remain intact for the major global indexes (MSCI ACWI, ACWI ex-US, EAFE, and EM). At this point,...

Logo
622 Views
Share
bearish•Cross Asset Strategy
•23 Dec 2019 05:16

Political Pit Stop 2020: Power Concentrates For the Thai Government

As the year closes, we note the five recent political developments in Thailand. On the balance, it leads to a stronger government and weaker...

bullish•MSCI World Index
•11 Dec 2019 07:37

Global Equities Headed Up and to the Right: Technology, Health Care Leading

Our weight of the evidence approach leads us to believe the market remains in the early stages of a broad-based advance, meaning a buy-the-dip...

Logo
611 Views
Share
x